[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 92 Agreed to Senate (ATS)]

  1st Session
S. RES. 92

  Expressing the sense of the Senate that funding for prostate cancer 
              research should be increased substantially.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 3, 1999

 Mrs. Boxer (for herself, Mr. Lautenberg, Mr. Reid, Mr. Jeffords, Mr. 
Schumer, Mr. Ashcroft, Mr. Mack, Mr. Coverdell, Mr. Helms, Mrs. Murray, 
Ms. Mikulski, Mr. Sarbanes, Mr. Thurmond, Mr. Torricelli, Mr. Cochran, 
Mr. Cleland, Mr. Inouye, Mr. Biden, Mr. Dorgan, Mr. Dodd, Mr. Edwards, 
    Mr. Graham, Mr. Breaux, Ms. Snowe, Mr. DeWine, Mr. Conrad, Ms. 
 Landrieu, Mrs. Feinstein, Mr. Feingold, Mrs. Lincoln, Mr. Warner, and 
 Mr. Lieberman) submitted the following resolution; which was referred 
       to the Committee on Health, Education, Labor, and Pensions

                            October 26, 1999

             Committee discharged; considered and agreed to

_______________________________________________________________________

                               RESOLUTION


 
  Expressing the sense of the Senate that funding for prostate cancer 
              research should be increased substantially.

Whereas in 1999, prostate cancer is expected to kill more than 37,000 men in the 
        United States and be diagnosed in over 180,000 new cases;
Whereas prostate cancer is the most diagnosed nonskin cancer in the United 
        States;
Whereas African Americans have the highest incidence of prostate cancer in the 
        world;
Whereas considering the devastating impact of the disease among men and their 
        families, prostate cancer research remains underfunded;
Whereas more resources devoted to clinical and translational research at the 
        National Institutes of Health will be highly determinative of whether 
        rapid advances can be attained in treatment and ultimately a cure for 
        prostate cancer;
Whereas the Congressionally Directed Department of Defense Prostate Cancer 
        Research Program is making important strides in innovative prostate 
        cancer research, and this Program presented to Congress in April of 1998 
        a full investment strategy for prostate cancer research at the 
        Department of Defense; and
Whereas the Senate expressed itself unanimously in 1998 that the Federal 
        commitment to biomedical research should be doubled over the next 5 
        years: Now, therefore, be it
    Resolved,

SECTION 1. SHORT TITLE.

    This resolution may be cited as the ``Prostate Cancer Research 
Commitment Resolution of 1999''.

SEC. 2. SENSE OF THE SENATE.

    It is the sense of the Senate that--
            (1) finding treatment breakthroughs and a cure for prostate 
        cancer should be made a national health priority;
            (2) significant increases in prostate cancer research 
        funding, commensurate with the impact of the disease, should be 
        made available at the National Institutes of Health and to the 
        Department of Defense Prostate Cancer Research Program; and
            (3) these agencies should prioritize prostate cancer 
        research that is directed toward innovative clinical and 
        translational research projects in order that treatment 
        breakthroughs can be more rapidly offered to patients.
                                 <all>